Tianyu Pharmaceutical (300702.SZ) subsidiary's drug Trelagliptin Hydrobromide Tablets approved

Zhitong Finance APP News, Tianyu Pharmaceutical (300702.SZ) announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. (referred to as "Nuode Pharmaceutical") recently received the Drug Registration Certificate approved and issued by the National Medical Products Administration for Teneligliptin Hydrobromide Tablets. The indication of the drug is: Monotherapy: This product can be used in combination with diet control and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus.